A simple rapid immunoassay for S-adenosylhomocysteine in plasma

被引:12
作者
Capdevila, Antonieta [1 ]
Burk, Raymond F. [2 ]
Freedman, Joshua [3 ]
Frantzen, Frank [4 ]
Alfbeim, Ingrid [5 ]
Wagner, Conrad [1 ,6 ]
机构
[1] Vanderbilt Univ, Dept Biochem, Sch Med, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Psychiat, Los Angeles, CA 90024 USA
[4] Axis Shield ASA, N-8031 Morkved, Bodo, Norway
[5] Biomed Innovasjon AS, N-0349 Oslo, Norway
[6] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
关键词
S-adenosylhomocysteine; immunoassay; plasma; vascular disease; human;
D O I
10.1016/j.jnutbio.2007.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The measurement of plasma S-adetiosylhomocysteine is a more sensitive indicator of the risk for vascular disease than is plasma homocysteine. Because the level of S-adenosylhomocysteine is normally in the nanomolar range, it has been difficult to measure and necessitated the development of complex fluorometric and mass-spectrophotometric methods. We have now adapted an existing immunoassay used for the measurement of homocysteine to the measurement of S-adenosylhomocysteine in plasma. This assay is sensitive down to the level of less than 0.1 pmol, and there is no interference by S-adenosylmethionine. The assay is carried out in microplates, allows the measurement of 12 samples per plate and can easily be carried out in a 4-h period. The method is applicable to plasma samples having S-adenosylhomocysteine concentrations ranging from 10 to 150 nM without dilution. The mean value for 16 normal subjects by this method was 18.9 +/- 1.4 nM (S.E.M.), compared with 17.8 +/- 1.4 nM obtained by a previously described method using two high-performance liquid chromatography columns with fluorescence derivatization. Mean values for seven cirrhotic patients were 46.5 +/- 3.3 nM by this new method compared with 44.6 +/- 5.3 by the former method. The ease and speed of this method should allow the widespread measurement of this important metabolite in laboratories without access to sophisticated equipment. Published by Elsevier Inc.
引用
收藏
页码:827 / 831
页数:5
相关论文
共 24 条
[1]
Baker RI, 2002, CEREBROVASC DIS, V13, P120
[2]
S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations [J].
Becker, A ;
Smulders, YM ;
Teerlink, T ;
Struys, EA ;
de Meer, K ;
Kostense, PJ ;
Jakobs, C ;
Dekker, JM ;
Nijpels, G ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDA .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (01) :17-25
[3]
S-ADENOSYLMETHIONINE LEVELS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS - A REVIEW [J].
BOTTIGLIERI, T ;
HYLAND, K .
ACTA NEUROLOGICA SCANDINAVICA, 1994, 89 :19-26
[4]
A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[5]
Measurement of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent isoindoles [J].
Capdevila, A ;
Wagner, C .
ANALYTICAL BIOCHEMISTRY, 1998, 264 (02) :180-184
[6]
Quantification of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent 1,N6-etheno derivatives:: an adaptation of previously described methodology [J].
Castro, R ;
Struys, EA ;
Jansen, EEW ;
Blom, HJ ;
de Almeida, IT ;
Jakobs, C .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (05) :963-968
[7]
Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].
Clarke, R ;
Collins, R ;
Lewington, S ;
Donald, A ;
Alfthan, G ;
Tuomilehto, J ;
Arnesen, E ;
Bonaa, K ;
Blacher, J ;
Boers, GHJ ;
Bostom, A ;
Bots, ML ;
Grobee, DE ;
Brattström, L ;
Breteler, MMB ;
Hofman, A ;
Chambers, JC ;
Kooner, JS ;
Coull, BM ;
Evans, RW ;
Kuller, LH ;
Evers, S ;
Folsom, AR ;
Freyburger, G ;
Parrot, F ;
Genst, J ;
Dalery, K ;
Graham, IM ;
Daly, L ;
Hoogeveen, EK ;
Kostense, PJ ;
Stehouwer, CDA ;
Hopknis, PN ;
Jacques, P ;
Selhub, J ;
Luft, FC ;
Jungers, P ;
Lindgren, A ;
Lolin, YI ;
Loehrer, F ;
Fowler, B ;
Mansoor, MA ;
Malinow, MR ;
Ducimetiere, P ;
Nygard, O ;
Refsum, H ;
Vollset, SE ;
Ueland, PM ;
Omenn, GS ;
Beresford, SAA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022
[8]
HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[9]
Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63
[10]
Frantzen F, 1998, CLIN CHEM, V44, P311